Treatment of breast cancer with trastuzumab during pregnancy

Journal of Clinical Oncology

Volumn 26, Issue 9, 2008, Pages 1567-1569

  Pant, Shubham ^a   Landon, Mark B ^b   Blumenfeld, Michael ^b   Farrar, William ^a   Shapiro, Charles L ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LAPATINIB; NAVELBINE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TRASTUZUMAB; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; MONOCLONAL ANTIBODY; QUINAZOLINE DERIVATIVE;

ADULT; ASPIRATION BIOPSY; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER SIZE; CASE REPORT; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE METASTASIS; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; LOW BIRTH WEIGHT; LUNG TUMOR; METASTASIS; NEWBORN; PAGET NIPPLE DISEASE; PATHOLOGY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURITY;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; LUNG NEOPLASMS; MASTECTOMY, MODIFIED RADICAL; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; QUINAZOLINES;

EID: 41149154859     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.0309     Document Type: Letter

References (30)

1. Yarden Y: Biology of HER2 and its importance in breast cancer. Oncology 61:1-13, 2001 (suppl 2)
2. Hudis CA: Trastuzumab - mechanism of action and use in clinical practice. N Engl J Med 357:39-51, 2007
3. Vogel CL, Cobleigh MA, Tripathy D, et al: Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20:719-726, 2002
4. Slamon DJ, Leyland-Jones B, Shak S, et al: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783-792, 2001
5. Romond EH, Perez EA, Bryant J, et al: trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353:1673-1684, 2005
6. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353:1659-1672, 2005
7. Carver JR, Shapiro CL, Ng A, et al: American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 25:3991-4008, 2007
8. Sekar R, Stone PR: Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol 110:507-510, 2007
9. Shrim A, Garcia-Bournissen F, Maxwell C, et al: Favorable pregnancy outcome following trastuzumab (Herceptin) use during pregnancy: Case report and updated literature review. Reprod Toxicol 23:611-613, 2007
10. Bader AA, Schlembach D, Tamussino KF, et al: Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol 8:79-81, 2007
11. Waterston AM, Graham J: Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol 24:321-322, 2006
12. Watson WJ: Herceptin (trastuzumab) therapy during pregnancy: Association with reversible anhydramnios. Obstet Gynecol 105:642-643, 2005
13. Fanale MA, Uyei AR, Theriault RL, et al: Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer 6:354-356, 2005
14. Mir O, Berveiller P, Ropert S, et al: Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol (in press) doi:10.1093/annonc/mdm460
15. Robinson AA, Watson WJ, and Leslie KK: Targeted treatment using monoclonal antibodies and tyrosine-kinase inhibitors in pregnancy. Lancet Oncol 8:738-743, 2007
16. www.gene.com/gene/products/information/oncology/herceptin/insert.jsp, 2007
17. Goodyer PR, Cybulsky A, Goodyer C: Expression of the epidermal growth factor receptor in fetal kidney. Pediatr Nephrol 7:612-615, 1993
18. Cybulsky AV, Goodyer PR, and McTavish AJ: Epidermal growth factor receptor activation in developing rat kidney. Am J Physiol 267:F428-F436, 1994
19. Goodyer PR, Fata J, Mulligan L, et al: Expression of transforming growth factor-alpha and epidermal growth factor receptor in human fetal kidneys. Mol Cell Endocrinol 77:199-206, 1991
20. Chailler P, Briere N: Mitogenic effects of EGF/TGF alpha and immunolocalization of cognate receptors in human fetal kidneys. Biofactors 7:323-335, 1998
21. Press MF, Cordon-Cardo C, Slamon DJ: Expression of the HER-2/neu protooncogene in normal human adult and fetal tissues. Oncogene 5:953-962, 1990
22. Cheung CY: Vascular endothelial growth factor activation of intramembranous absorption: A critical pathway for amniotic fluid volume regulation. J Soc Gynecol Invest 11:63-74, 2004
23. Kumar R, Yarmand-Bagheri R: The role of HER2 in angiogenesis. Semin Oncol 28:27-32, 2001
24. Petit AM, Rak J, Hung MC, et al: Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol 151:1523-1530, 1997
25. Negro A, Brar BK, Lee KF: Essential roles of Her2/erbB2 in cardiac development and function. Recent Prog Horm Res 59:1-12, 2004
26. Garratt AN, Ozcelik C, Birchmeier C: ErbB2 pathways in heart and neural diseases. Trends Cardiovasc Med 13:80-86, 2003
27. Koren G, Pastuszak A, Ito S: Drugs in pregnancy. N Engl J Med 338:1128-1137, 1998
28. Duffy CM, Allen SM, Clark MA: Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 23:766-773, 2005
29. Thewes B, Meiser B, Taylor A, et al: Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 23:5155-5165, 2005
30. Partridge AH, Gelber S, Peppercorn J, et al: Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22:4174-4183, 2004